Stock Track | Lantheus Plunges 6.52% Pre-market as Q1 Earnings Miss Estimates

Stock Track

May 07, 2025

Shares of Lantheus (LNTH) tumbled 6.52% in pre-market trading on Wednesday following the release of its first-quarter 2025 financial results, which fell short of analyst expectations. The medical imaging and diagnostics company reported earnings that disappointed investors, triggering a sell-off in early trading.

Lantheus announced adjusted earnings per share (EPS) of $1.53 for Q1 2025, missing the IBES estimate of $1.66. Revenue for the quarter came in at $372.8 million, also falling short of the projected $379 million. The company's GAAP EPS stood at $1.02 for the quarter. Despite the earnings miss, Lantheus reported a robust free cash flow of $98.8 million for the period.

The market's negative reaction highlights investor sensitivity to earnings misses, especially for growth-oriented companies in the healthcare sector. While Lantheus continues to generate significant cash flow, the failure to meet analyst expectations has raised concerns about the company's growth trajectory and near-term prospects, leading to the sharp pre-market decline.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1105763537"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1105763537\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1105763537?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-07 19:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1105763537","market":"hk","top_or_hot":-1,"title":"Stock Track | Lantheus Plunges 6.52% Pre-market as Q1 Earnings Miss Estimates","media":"Stock Track","content":"<p>Shares of Lantheus (LNTH) tumbled 6.52% in pre-market trading on Wednesday following the release of its first-quarter 2025 financial results, which fell short of analyst expectations. The medical imaging and diagnostics company reported earnings that disappointed investors, triggering a sell-off in early trading.</p>\n\n<p>Lantheus announced adjusted earnings per share (EPS) of $1.53 for Q1 2025, missing the IBES estimate of $1.66. Revenue for the quarter came in at $372.8 million, also falling short of the projected $379 million. The company's GAAP EPS stood at $1.02 for the quarter. Despite the earnings miss, Lantheus reported a robust free cash flow of $98.8 million for the period.</p>\n\n<p>The market's negative reaction highlights investor sensitivity to earnings misses, especially for growth-oriented companies in the healthcare sector. While Lantheus continues to generate significant cash flow, the failure to meet analyst expectations has raised concerns about the company's growth trajectory and near-term prospects, leading to the sharp pre-market decline.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Lantheus Plunges 6.52% Pre-market as Q1 Earnings Miss Estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Lantheus Plunges 6.52% Pre-market as Q1 Earnings Miss Estimates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-05-07 19:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Lantheus (LNTH) tumbled 6.52% in pre-market trading on Wednesday following the release of its first-quarter 2025 financial results, which fell short of analyst expectations. The medical imaging and diagnostics company reported earnings that disappointed investors, triggering a sell-off in early trading.</p>\n\n<p>Lantheus announced adjusted earnings per share (EPS) of $1.53 for Q1 2025, missing the IBES estimate of $1.66. Revenue for the quarter came in at $372.8 million, also falling short of the projected $379 million. The company's GAAP EPS stood at $1.02 for the quarter. Despite the earnings miss, Lantheus reported a robust free cash flow of $98.8 million for the period.</p>\n\n<p>The market's negative reaction highlights investor sensitivity to earnings misses, especially for growth-oriented companies in the healthcare sector. While Lantheus continues to generate significant cash flow, the failure to meet analyst expectations has raised concerns about the company's growth trajectory and near-term prospects, leading to the sharp pre-market decline.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LNTH","symbol_name":"Lantheus Holdings, Inc.","start_time":0,"source_url":"","article_id":"1105763537","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1105763537","pubTimestamp":1746615867,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Lantheus  tumbled 6.52% in pre-market trading on Wednesday following the release of its first-quarter 2025 financial results, which fell short of analyst expectations. The medical imaging and diagnostics company reported earnings that disappointed investors, triggering a sell-off in early trading.Lantheus announced adjusted earnings per share  of $1.53 for Q1 2025, missing the IBES estimate of $1.66. Revenue for the quarter came in at $372.8 million, also falling short of the projected","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LNTH":"Lantheus Holdings, Inc."},"translate_title":"由于第一季度盈利未达预期，股票跟踪Lantheus盘前暴跌6.52%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LNTH":1},"content_text":"Shares of Lantheus (LNTH) tumbled 6.52% in pre-market trading on Wednesday following the release of its first-quarter 2025 financial results, which fell short of analyst expectations. The medical imaging and diagnostics company reported earnings that disappointed investors, triggering a sell-off in early trading.\nLantheus announced adjusted earnings per share (EPS) of $1.53 for Q1 2025, missing the IBES estimate of $1.66. Revenue for the quarter came in at $372.8 million, also falling short of the projected $379 million. The company's GAAP EPS stood at $1.02 for the quarter. Despite the earnings miss, Lantheus reported a robust free cash flow of $98.8 million for the period.\nThe market's negative reaction highlights investor sensitivity to earnings misses, especially for growth-oriented companies in the healthcare sector. While Lantheus continues to generate significant cash flow, the failure to meet analyst expectations has raised concerns about the company's growth trajectory and near-term prospects, leading to the sharp pre-market decline.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}